Annual Total Liabilities
$130.21 M
+$1.13 M+0.88%
December 31, 2023
Summary
- As of February 26, 2025, BTAI annual total liabilities is $130.21 million, with the most recent change of +$1.13 million (+0.88%) on December 31, 2023.
- During the last 3 years, BTAI annual total liabilities has risen by +$116.97 million (+883.46%).
- BTAI annual total liabilities is now at all-time high.
Performance
BTAI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$134.53 M
-$5.21 M-3.73%
September 30, 2024
Summary
- As of February 26, 2025, BTAI quarterly total liabilities is $134.53 million, with the most recent change of -$5.21 million (-3.73%) on September 30, 2024.
- Over the past year, BTAI quarterly total liabilities has stayed the same.
- BTAI quarterly total liabilities is now -13.03% below its all-time high of $154.69 million, reached on March 31, 2024.
Performance
BTAI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BTAI Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.9% | 0.0% |
| 3 y3 years | +883.5% | 0.0% |
| 5 y5 years | +2694.2% | 0.0% |
BTAI Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +632.7% | -13.0% | +690.2% |
| 5 y | 5-year | at high | +1271.1% | -13.0% | +1316.5% |
| alltime | all time | at high | >+9999.0% | -13.0% | +9585.0% |
BioXcel Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $134.53 M(-3.7%) |
| Jun 2024 | - | $139.74 M(-9.7%) |
| Mar 2024 | - | $154.69 M(+18.8%) |
| Dec 2023 | $130.21 M(+0.9%) | $130.21 M(-7.7%) |
| Sep 2023 | - | $141.06 M(+5.1%) |
| Jun 2023 | - | $134.23 M(+5.6%) |
| Mar 2023 | - | $127.10 M(-1.5%) |
| Dec 2022 | $129.08 M(+626.3%) | $129.08 M(+9.5%) |
| Sep 2022 | - | $117.83 M(+40.3%) |
| Jun 2022 | - | $83.97 M(+393.2%) |
| Mar 2022 | - | $17.02 M(-4.2%) |
| Dec 2021 | $17.77 M(+34.2%) | $17.77 M(+12.7%) |
| Sep 2021 | - | $15.78 M(+15.2%) |
| Jun 2021 | - | $13.70 M(+0.3%) |
| Mar 2021 | - | $13.65 M(+3.1%) |
| Dec 2020 | $13.24 M | $13.24 M(-25.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $17.81 M(+4.4%) |
| Jun 2020 | - | $17.07 M(+29.0%) |
| Mar 2020 | - | $13.23 M(+39.3%) |
| Dec 2019 | $9.50 M(+103.8%) | $9.50 M(+2.4%) |
| Sep 2019 | - | $9.28 M(+1.7%) |
| Jun 2019 | - | $9.12 M(+14.6%) |
| Mar 2019 | - | $7.96 M(+70.8%) |
| Dec 2018 | $4.66 M(+99.4%) | $4.66 M(+128.1%) |
| Sep 2018 | - | $2.04 M(+47.1%) |
| Jun 2018 | - | $1.39 M(-67.0%) |
| Mar 2018 | - | $4.21 M(+80.4%) |
| Dec 2017 | $2.34 M(+606.0%) | $2.34 M |
| Dec 2016 | $331.00 K(-89.8%) | - |
| Jul 2016 | $3.24 M(-26.5%) | - |
| Jul 2015 | $4.40 M(+14.8%) | - |
| Jul 2014 | $3.83 M | - |
FAQ
- What is BioXcel Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual total liabilities year-on-year change?
- What is BioXcel Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly total liabilities year-on-year change?
What is BioXcel Therapeutics annual total liabilities?
The current annual total liabilities of BTAI is $130.21 M
What is the all time high annual total liabilities for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual total liabilities is $130.21 M
What is BioXcel Therapeutics annual total liabilities year-on-year change?
Over the past year, BTAI annual total liabilities has changed by +$1.13 M (+0.88%)
What is BioXcel Therapeutics quarterly total liabilities?
The current quarterly total liabilities of BTAI is $134.53 M
What is the all time high quarterly total liabilities for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly total liabilities is $154.69 M
What is BioXcel Therapeutics quarterly total liabilities year-on-year change?
Over the past year, BTAI quarterly total liabilities has changed by $0.00 (0.00%)